Myoblast transplantation for cardiac repair: A clinical perspective

Molecular Therapy

Volumn 9, Issue 1, 2004, Pages 14-23

  Haider, Husnain Kh ^a   Tan, Alvin C K ^a   Aziz, Salim ^b   Chachques, Juan C ^c   Sim, Eugene K W ^a,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b WASHINGTON ADVENTIST HOSPITAL   (United States)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Cardiac; Clinical; Heart failure; Human; Myoblast; Transplantation

Indexed keywords

AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; CELL CYCLE; CELL FUNCTION; CELL REGENERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CORONARY ARTERY BYPASS GRAFT; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HUMAN; INCIDENCE; MORTALITY; MYOBLAST; NONHUMAN; POSTOPERATIVE COMPLICATION; REVIEW; SAFETY;

ANIMALIA;

EID: 1142287430     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2003.10.009     Document Type: Review

References (86)

1. American Heart Association (2002). Heart and Stroke Statistical Update. Am. Heart Assoc.
2. Al-Radi, O. O., Rao, V., Li, R. K., Yau, T., and Weisel, R. D. (2003). Cardiac cell transplantation: Closer to bedside. Ann. Thoracic Surg. 75: S674-S677.
3. Vilquin, J. -T., Marolleau, J. -P., Hagege, A., Menasche, P., Fiszman, M., and Schwartz, K. (2002). Cell transplantation for post ischemic heart failure. Arch. Mol. Coeur. 95: 1219-1225.
4. Ranjan, A., Tarigopula, L., Srivastava, R. K., Obasanjo, O. O., and Obah, E. (2003). Effectiveness of the clinical pathway in the management of congestive heart failure. South Med. J. 96: 661-663.
5. Ventura, H. O., and Kalapura, T. (2003). Beta-blocker therapy and severe heart failure: myth or reality? Congest. Heart Fail. 9: 197-202.
6. Christiansen, S., Brose, S., and Autschbach, R. (2003). Surgical therapy of end-stage heart failure. Herz 28: 380-392.
7. Jayakar, D. V. (2003). Surgical treatment for chronic heart failure. Compr. Ther. 29: 66-76.
8. Chachques, J. C., et al. (2002). From dynamic to cellular cardiomyoplasty. J. Card. Surg. 17: 194-200.
9. Carraro, U., and Rigatelli, G. (2003). Cardiac-bio-assists: biological approaches to support or repair cardiac muscle. Ital. Heart J. 4: 152-162.
10. Oz, M. C., et al. (2003). Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann. Surg. 238: 577-583.
11. Chiu, R. C. (2001). Therapeutic cardiac angiogenesis and myogenesis: The promises and challenges of a new frontier. J. Thoracic Cardiovasc. Surg. 122: 851-852.
12. Gulbins, H., Meiser, B. M., Reichenspurner, H., and Reichart, B. (2002). Cell transplantation: A potential therapy for cardiac repair in the future? Heart Surg Forum 5: E28- E34.
13. Hagege, A. A., and Menasche, P. (2000). Cellular cardiomyoplasty: A new hope in heart failure? Heart 84: 465-466.
14. Claycomb, W. C. (1992). Control of cardiac-muscle cell-division. Trends Cardiovasc. Med. 2: 231-236.
15. Li, F. Q., Wang, X. J., Capasso, J. M., and Gerdes, A. M. (1996). Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell. Cardiol. 28: 173-176.
16. Anversa, P., Leri, A., Kajstura, J., and Nadal-Ginard, B. (2002). Myocyte growth and cardiac repair. J. Mol. Cell. Cardiol. 34: 91-105.
17. Anversa, R., Torella, D., Kajstura, J., Nadal-Ginard, B., and Leri, A. (2002). Myocardial regeneration. Eur. Heart J. Suppl. 4(G): G67-G71.
18. Beltrami, A. P., et al. (2001). Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344: 1750-1757.
19. Nadal-Ginard, B., Kajstura, J., Leri, A., and Anversa, P. (2003). Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ. Res. 92: 139-150.
20. Chiu, R. C. J., Zibaitis, A., and Kao, R. L. (1995). Cellular cardiomyoplasty: Myocardial regeneration with satellite cell implantation. Ann. Thoracic Surg. 60: 12-18.
21. El Oakley, R. M., Ooi, O. C., Bongso, A., and Yacoub, M. H. (2001). Myocyte transplantation for myocardial repair: A few good cells can mend a broken heart. Ann. Thoracic Surg. 71: 1724-1733.
22. Semsarian, C. (2002). Stem cells in cardiovascular disease: from cell biology to clinical therapy. Intern. Med. J. 32: 259-265.
23. Dowell, J. D., Rubart, M., Pasumarthi, K. B. S., Soonpaa, M. H., and Field, L. J. (2003). Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc. Res. 58: 336-350.
24. Penn, M. S., Francis, G. S., Ellis, S. G., Young, J. B., McCarthy, P. M., and Topol, E. J. (2002). Autologous cell transplantation for the treatment of damaged myocardium. Prog. Cardiovasc. Dis. 45: 21-32.
25. Atkins, B. Z., Hueman, M. T., Meuchel, J. M., Cottman, M. J., Hutcheson, K. A., and Taylor, D. A. (1999). Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium. J. Heart Lung Transplant 18: 1173-1180.
26. Murry, C. E., Whitney, M. L., and Reinecke, H. (2002). Muscle cell grafting for the treatment and prevention of heart failure. J. Card. Fail. 8: S532-S541.
27. Tang, G. H., et al. (2003). Cell transplantation to improve ventricular function in the failing heart. Eur. J. Cardiothoracic Surg. 23: 907-916.
28. Taylor, D. A., et al. (1998). Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nat. Med. 4: 929-933.
29. Hamano, K., et al. (2002). Therapeutic angiogenesis induced by local autologous bone marrow cell implantation. Ann. Thoracic Surg. 73: 1210-1215.
30. Chedrawy, E. G., Wang, J. S., Nguyen, D. M., Shum-Tim, D., and Chiu, R. C. (2002). Incorporation and integration of implanted myogenic and stem cells into native myocardial fibers: Anatomic basis for functional improvements. J. Thoracic Cardiovasc. Surg. 124: 584-590.
31. Tomita, S., et al. (2002). Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J. Thoracic Cardiovasc. Surg. 123: 1132-1140.
32. Chekanov, V., and Kipshidze, N. (2003). Angiogenesis by means of endothelial cell transplantation. J. Thoracic Cardiovasc. Surg. 125: 441-442.
33. Hamano, K., et al. (2001). Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease. Jpn. Circ. J. 65: 845-847.
34. Sakai, T., Ling, Y., Payne, T. R., and Huard, J. (2002). The use of ex vivo gene transfer based on muscle-derived stem cells for cardiovascular medicine. Trends Cardiovasc. Med. 12: 115-120.
35. Suzuki, K., et al. (2001). Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104: I207-I212.
36. Tse, H. F., Kwong, Y. L., Chan, K. F., Lo, G., Ho, C. L., and Lau, C. (2003). Angiogenesis in ischemic myocardium by intra-myocardial autologous bone marrow mononuclear cell implantation. Lancet 361: 47-49.
37. Yau, T. M., Fung, K., Weisel, R. D., Fujii, T., Mickle, D. A., and Li, R. K. (2001). Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 104: I218-I222.
38. Atkins, B. Z. (2002). Results of cellular therapy for ischemic myocardial dysfunction. Minerva Cardioangiol. 50: 333-341.
39. Reinlib, L., and Field, L. (2000). Cell transplantation as future therapy for cardiovascular disease? A Workshop of the National Heart, Lung and Blood Institute. Circulation 101: e182-e187.
40. Al Attar, N., et al. (2003). Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat. Cardiovasc Res. 58: 142-148.
41. Henningson, C. T., Jr., Stanislaus, M. A., and Gewirtz, A. M. (2003). Embryonic and adult stem cell therapy. Allergy Clin. Immunol. 111(2 Suppl.): S745-S753.
42. Hutcheson, K. A., Atkins, B. Z., Hueman, M. T., Hopkins, M. B., Glower, D. D., and Taylor, D. A. (2000). Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant 9: 359-368.
43. Kim, W. G., Park, J. J., Chung, D. H., and Na, C. Y. (2002). Autologous cardiomyocyte transplantation in an ovine myocardial infarction model. Int. J. Artif. Org. 25: 61-66.
44. Scorsin, M., et al. (2000). Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on post infarction left ventricular function. J. Thoracic Cardiovasc. Surg. 119: 1169-1175.
45. Yoo, K. J., Li, R. K., Weisel, R. D., Mickle, D. A., Li, G., and Yau, T. M. (2000). Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy. Ann. Thoracic Surg. 70: 859-865.
46. Yoo, K. J., et al. (2002). Smooth muscle cells transplantation is better than heart cells transplantation for improvement of heart function in dilated cardiomyopathy. Yonsei Med. J. 43: 296-303.
47. Li, R. K., et al. (1996). Cardiomyocyte transplantation improves heart function. Ann. Thoracic Surg. 62: 654-661.
48. Reffelmann, T., Dow, J. S., Dai, W., Hale, S. L., Simkhovich, B. Z., and Kloner, R. A. (2003). Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium. J. Mol. Cell. Cardiol. 35: 607-613.
49. Rubart, M., Pasumarthi, K. B., Nakajima, H., Soonpaa, M. H., Nakajima, H. O., and Field, L. J. (2003). Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ. Res. 92: 1217-1224.
50. Hagege, A. A., et al. (2003). Viability and differentiation of autologous skeletal myoblast grafts in ischemic cardiomyopathy. Lancet 361: 491-492.
51. Pagani, F. D., et al. (2003). Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: Histological analysis of cell survival and differentiation. J. Am. Coll. Cardiol. 41: 879-888.
52. Ghostine, S., et al. (2002). Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106: I131-I136.
53. Jain, M., et al. (2001). Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 103: 1920-1927.
54. Rajnoch, C., Chachques, J. C., Berrebi, A., Bruneval, P., Benoit, M. O., and Carpentier, A. (2001). Cellular therapy reverses myocardial dysfunction. J. Thoracic Cardiovasc. Surg. 121: 871-878.
55. Reinecke, H., Poppa, V., and Murry, C. E. (2002). Skeletal muscle stem cells do not trans-differentiate into cardiomyocytes after cardiac grafting. J. Mol. Cell. Cardiol. 34: 241-249.
56. Leobon, B., Garcin, I., Menasche, P., Vilquin, J. -T., Audiant, E., and Charpak, S. (2002). Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc. Natl. Acad. Sci. USA 100: 7808-7811.
57. Menasche, P., et al. (2001). Myoblast transplantation for heart failure. Lancet 357: 279-280.
58. Chavey, W. E., II, Blaum, C. S., Bleske, B. E., Harrison, R. V., Kesterson, S., and Nicklas, J. M. (2001). Guideline for the management of heart failure caused by systolic dysfunction. Part I. Guideline development, etiology and diagnosis. Am. Fam. Physician 64: 769-774.
59. Chavey, W. E., II, Blaum, C. S., Bleske, B. E., Harrison, R. V., Kesterson, S., and Nicklas, J. M. (2001). American Heart Association guideline for the management of heart failure caused by systolic dysfunction. Part II. Treatment. Am. Fam. Physician 64: 1045-1054.
60. Stamm, C., et al. (2003). Autologous bone marrow stem-cell transplantation for myocardial regeneration. Lancet 361: 45-46.
61. Strauer, B. E., et al. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913-1918.
62. Siminiak, T., Kalawski, R., and Kurpisz, M. (2002). Myoblast transplantation in the treatment of post infarction myocardial contractility impairment - A case report. Kardiol. Pol. 53: 131.
63. Zhang, F. M., et al. (2003). Clinical cellular cardiomyoplasty: technical considerations. J. Card. Surg. 18: 268-273.
64. Menasche, P., et al. (2003). Autologous skeletal myoblast transplantation for severe post-infarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41: 1078-1083.
65. Siminiak, T., et al. (2002). Transplantation of autologous skeletal myoblasts in the treatment of patients with post infarction heart failure. Circulation 106: II-636 [Abstract 3137].
66. Chachques, J. C., et al. (2002). Treatment of heart failure with autologous skeletal myoblasts. Herz 27: 570-578.
67. Chachques, J. C., Gonzalez, J. H., and Trainini, J. C. (2003). Cardiomioplast. Cel. Rev. Argent. Cardiol. 71: 138-145.
68. Dib, N., et al. (2002). Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Interim results from the United States experience. Circulation 106(Suppl. II): II-463 [Abstract 2291].
69. Kao, R. L., Zhang, F., Yiang, Z. -J., Gao, X., and Li, C. (2003). Cellular cardiomyoplasty using autologous satellite cells: from experimental to clinical study. Basic Appl. Myol. 13: 23-28.
70. Law, P. K., Fang, G., Chua, F., Kakuchaya, T., and Bockeria, L. A. (2003). First-in-Man myoblast allografts for heart degeneration. Int. J. Med. Implants Devices 1: 100-155 [Abstract].
71. Glinanes, M., Loubani, M., Davies, J., Chin, D., Pasi, J., and Bell, P. (2002). Safety and efficacy of transplantation of autologous bone marrow into scarred myocardium for the enhancement of cardiac function in man. Circulation 106(Suppl. II): II-463 [Abstract 2292].
72. Tran, N., et al. (2002). Autologous cell transplantation and cardiac tissue engineering: potential applications in heart failure. Biorheology 40: 411-415.
73. + cells or NK cells. Cell Transplant, 9: 489-502.
74. Irintchev, A., Zweyer, M., and Wernig, A. (1995). Cellular and molecular reactions in mouse muscles after myoblast implantation. J. Neurocytol. 24: 319-331.
75. Pouzet, B., et al. (2000). Intramyocardial transplantation of autologous myoblasts: Can tissue processing be optimized? Circulation 102: III210-III215.
76. Skuk, D., Caron, N., Goulet, M., Roy, B., Espinosa, F., and Tremblay, J. P. (2002). Dynamics of the early immune cellular reactions after myogenic cell transplantation. Cell Transplant. 11: 671-681.
77. Hodgetts, S. I., Spencer, M. J., and Grounds, M. D. (2003). A role for natural killer cells in the rapid death of cultured donor myoblasts after transplantation. Transplantation 75: 863-871.
78. Smythe, G. M., and Grounds, D. D. (2000). Exposure to tissue culture conditions can adversely affect myoblast behavior in vivo in whole muscle grafts: Implications for myoblast transfer therapy. Cell Transplant. 9: 379-393.
79. Rozwadowska, N., Fiszer, D., Siminiak, T., Kalawski, R., and Kurpisz, M. (2002). Evaluation of in vitro culture of human myoblasts for tissue auto transplants to the post-infarcted heart. Kardiol. Pol. 57: 233.
80. Menasche, P. (2002). Myoblast transplantation: feasibility, safety and efficacy. Ann. Med. 34: 314-315.
81. Li, R. K., Mickle, D. A., Weisel, R. D., Rao, V., and Jia, Z. Q. (2001). Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann. Thoracic Surg. 72: 1957-1963.
82. Perin, E. C., et al. (2003). Trans-endocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107: 2294-2302.
83. Thompson, C. A., et al. (2003). Percutaneous transvenous cellular cardiomyoplasty: a novel non-surgical approach for myocardial cell transplantation. J. Am. Coll. Cardiol. 41: 1964-1971.
84. Chazaud, B., et al. (2003). Endoventricular porcine autologous myoblast transplantation can be successfully achieved with minor mechanical cell damage. Cardiovasc. Res. 58: 444-450.
85. Dib, N., et al. (2002). Endoventricular transplantation of allogeneic skeletal myoblasts in a porcine model of myocardial infarction. J. Endovasc. Ther. 9: 313-319.
86. Grossman, P. M., Han, Z. G., Palasis, M., Barry, J. J., and Lederman, R. J. (2002). Incomplete retention after direct myocardial injection. Cath. Cardiovasc. Intervent. 55: 392-397.